Artificial Intelligence approach to verify irrationality of FDCs listed by CDSCO
DOI:
https://doi.org/10.25081/rip.2023.v13.8464Keywords:
Artificial Intelligence, ChatGPT, BARD, SwissADME, FDC irrationality, CDSCOAbstract
Various Artificial Intelligence (AI) tools were utilized to verify the irrationality of Fixed-Dose-Combinations (FDCs) which were already proven irrational by CDSCO. SwissADME, one of the AI tools was able to generate properties of FDCs by using two-dimensional structures downloaded from Pubchem (a free data source). Another interesting finding was obtained by using two different AI tools ChatGPT and BARD. These AI tools identified uncommon comparative properties and predicted most of the FDCs are irrational. This suggests that these AI tools can play a crucial role in identifying irrationality in drugs. Additionally, the study looked into drug–drug interactions, and it was found that most of the FDCs are exhibited such interactions. AI tools were capable of analysing the irrationality of a significant number of drugs. However, SwissADME, one of the AI tools has limited capability in processing large structures. This proves the further need for improvements in AI technology to produce more accurate and comprehensive analyses.
Downloads
References
Agrawal, P. (2018). Artificial Intelligence in Drug Discovery and Development. Journal of Pharmacovigilance, 6(2), 1-2. https://doi.org/10.4172/2329-6887.1000e173
Al Azzam, K. M. (2022). SwissADME and pkCSM Webservers Predictors: an integrated Online Platform for Accurate and Comprehensive Predictions for In Silico ADME/T Properties of Artemisinin and its Derivatives. Complex Use Mineral Resources, 325(2), 14-21. https://doi.org/10.31643/2023/6445.13
CDSCO. (2023). Central Drugs Standard Control Organization. Retrieved from: https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTAwMDY=
Chaudhari, M. K., & Patel, V. P. (2020). A REVIEW ARTICLE ON ARTIFICIAL INTELLIGENCE; Change in Modern Techniques of pharmaceutical Formulation and Development. Journal of Emerging Technologies and Innovative Research, 7(9), 1466-1473.
Chen, W., Liu, X., Zhang, S., & Chen, S. (2023). Artificial Intelligence for drug discovery: Resources, methods, and applications. Molecular Therapy: Nucleic Acids, 31, 691-702. https://doi.org/10.1016/j.omtn.2023.02.019
Diana, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
Eysenbach, G. (2023). The Role of ChatGPT, Generative Language Models, and Artificial Intelligence in Medical Education: A Conversation with ChatGPT and a call for Papers. Journal of Medical Internet Research Medical Education. https://doi.org/10.2196/46885
Jang, I.-J. (2019). Artificial intelligence in drug development: clinical pharmacologist perspective. Translation and Clinical Pharmacology, 27(3), 87-88. https://doi.org/10.12793/tcp.2019.27.3.87
Krishnaveni, C., Arvapalli, S., Sharma, J. V. C., & Divya, K. (2019). Artificial Intelligence in Pharma Industry - A Review. International Journal of Innovative Pharmaceutical Sciences and Research, 7(10), 37-50.
Lubowitz, J. H. (2023). ChatGPT, An Artificial intelligence Chatbot, Is Impacting Medical Literature. Arthroscopy: The Journal of Arthroscopic and Related Surgery, 39(5), 1121-1122. https://doi.org/10.1016/j.arthro.2023.01.015
Mahanthesh, M. T., Ranjith, D., Yaligar, R., Jyothi, R., Narappa, G., & Ravi, M. V. (2020). Swiss ADME prediction of phytochemicals present in Butea monosperma (Lam.) Taub. Journal of Pharmacognosy and Phytochemistry, 9(3), 1799-1809.
Patel, V., & Shah, M., (2022). Artificial intelligence and machine learning in drug discovery and development. Intelligent Medicine, 2(3), 134-140, https://doi.org/10.1016/j.imed.2021.10.001
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2020). Artificial Intelligence in drug discovery and development. Drug Discovery Today, 26(1), 80-93. https://doi.org/10.1016/j.drudis.2020.10.010
Ram, B., & Verma, P. (2023). Artificial Intelligence AI-based Chatbot study of Chatbot, Google AI Bard and Baidu Ai. World Journal of Advanced Engineering Technology and Sciences, 8(1), 258-261. https://doi.org/10.30574/wjaets.2023.8.1.0045
Rana, S., & Prakash, P. (2021). In Silico pharmacokinetic Prediction for New Fixed Dose Combinations - A Lesson to Learn. Inventi Rapid: Pharmacokinetics & Pharmacodynamics, 2021(2), 1-8.
Sallam, M. (2023). ChatGPT Utility in Healthcare Education, Research, and Practice: Systematic Review on the Promising Perspectives and Valid Concerns. Healthcare, 11(6), 887. https://doi.org/10.3390/healthcare11060887
Sellwood, M. A., Ahmed, M., Segler, M. H. S., & Brown, N. (2018) Artificial Intelligence in drug discovery. Future Medicinal Chemistry, 10(17), 2025-2028. https://doi.org/10.4155/fmc-2018-0212
Sharma, V. K., & Bharatam, P. V. (2022). Artificial Intelligence in Drug Discovery (AIDD). Current Research & Information on Pharmaceutical Sciences, 16(1), 3-7.
Siad, S. M. (2023). The Promise and Perils of Google's Bard for Scientific Research. Humanities commons. https://doi.org/10.17613/yb4n-mc79
Published
How to Cite
Issue
Section
Copyright (c) 2023 Research in Pharmacy
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
.